Payers
Regenerex for Payers
“We utilize capitated pay and ‘at risk’ programs to define maximum expenditure levels and enable payers to budget chronic wound health care programs with fixed patient costs. We add predictability and identify savings for payers.” – KEN PERRY, CFO
Regenerex delivers a complete chronic wound closure program for State, Federal and managed care organizations, and managed care provider groups. We implement these solutions in a capitated, value-based contract environment.
Regenerex Program Directives
- Improving healing rates with all enrolled chronic wound patients
- Reducing amputation rates
- Significant cost reduction to the payers on all enrolled chronic wound patients
- Minimized risk and cost exposure of outliers
- Up to date outcomes, quality and financial reports specific to the payer needs
Turnkey Program
The Regenerex Pharma Complete Wound Closure Program provides a complete turnkey system with the following components:
- All woundcare products
- AI supported proprietary woundcare EMR
- Regenerex wound closure protocols
- Comprehensive training program
- On-boarding and on-going training.
- Data collection and reporting
- On-going support and monitoring of IT support, RGPX Medical directors and staff
- RGPX will provide healthcare provider staffing for a given geography, if there is not a provider network in place
- Capitated, At Risk cost payment model
- Predictable outcomes
- Predictable costs
- More accurate financial modeling
- Reduced amputations
- Staffing
- AI augmented support systems
- Monitoring and reporting
Our Research
Regenerex is continuously testing for safety and efficacy.
Quick Links
Need help?
If you have questions regarding our payer capitated, value-based program, please contact us directly.
